Novel coronavirus detection kit based on Crisper

A technology for detection kits and coronaviruses, which can be used in the determination/inspection of microorganisms, resistance to vector-borne diseases, and measurement devices, etc. It can solve problems such as insufficient specificity, high dependence on special equipment, and insufficient sensitivity

Inactive Publication Date: 2020-08-14
宿迁市第一人民医院
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, most of the detection kits using the RT-PCR method on the market require a long time, are highly de...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel coronavirus detection kit based on Crisper
  • Novel coronavirus detection kit based on Crisper
  • Novel coronavirus detection kit based on Crisper

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 Design and acquisition of crRNA targeting virus-specific sites

[0027] 1. Discovery of novel coronavirus detection sites based on CRISPR-LwaCas13a system

[0028] According to the latest "RT-PCR Detection Guide" issued by CDC, the inventor obtained the specific region of the new coronavirus. Design crRNA for these different regions and construct CRISPR / LwaCas13a system for research. The results show that the detection site based on the CRISPR / LwaCas13a system has a good detection effect with the region sequence shown in SEQ ID NO.1-2.

[0029] Table 1

[0030]

[0031] 2. Design of crRNA targeting specific regions

[0032] Since the CRISPR-Cas13a system is a targeted DNA gene editing system, in which Cas13a combines with crRNA to form a monitoring complex, the crRNA design requires: crRNA includes a protein anchor sequence and a guide sequence, and the sequence format is: 5`-and Cas13a The protein-binding anchor sequence-crRNA guide sequence-3`, the gu...

Embodiment 2

[0038] Embodiment 2 Detection kit and detection method of novel coronavirus

[0039] 1. The composition of the new coronavirus detection kit

[0040] This kit includes:

[0041] (1) crRNA targeting the C-terminal partial sequence: its sequence is shown in any one of SEQ ID NO.3-4.

[0042] (2) crRNA targeting N-terminal partial sequence: its sequence is shown in any one of SEQ ID NO.5-6.

[0043] (3) A specific fluorescent probe (using a general molecular beacon purchased from Thermo Fisher, such as 5'- / 56-FAM / mArUrGrGrGrCmAmArArUrGrGrCmA / 3Bio / -3');

[0044] (4) LwaCas13a protein;

[0045] (5) RNase inhibitor, T7 polymerase, ribonucleic acid solution and magnesium chloride solution.

[0046] Preferably, in order to make highly sensitive and highly specific detection of trace amounts of 2019-nCov virus, it is necessary to pre-amplify the nucleic acid of the virus to increase the abundance. Therefore, the RPA amplification method is preferably used. The new coronavirus detec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a novel coronavirus detection kit based on Crisper. The crRNA comprises a crRNA targeting a C-terminal part sequence and a crRNA targeting an N-terminal partial sequence, wherein the sequence of the crRNA targeting the C-terminal part sequence is shown as any one of SEQ ID NO.3 and SEQ ID NO.4, and the crRNA targeting the N-terminal partial sequence is shown as any one of SEQ ID NO.5 and 6. The invention alsohe invention relates to the crRNA related to the C-terminal partial sequence and the N-terminal partial sequence of a novel coronavirus. Through application of a method for mutation detection by using the crRNA in combination with a CRISPR-LwaCas13a system, the method has the advantages of low cost, repeated detection for multiple times, simplicity, no dependenceon a special fluorescent quantitative PCR instrument, high detection speed, high sensitivity (the lowest detection limit reaches 10<-2> copies/[mu]L) and strong specificity, and can be used to detectwhether the target nucleic acid is contained or not in a short time through the change of a fluorescence signal.

Description

technical field [0001] The invention relates to the technical field of biological detection, in particular to a Crisper-based novel coronavirus detection kit. Background technique [0002] At present, most of the detection kits using the RT-PCR method on the market require a long time, are highly dependent on special equipment, are not specific enough, and have insufficient sensitivity to cause false negatives. Therefore, there is an urgent need to develop a fast, highly specific and highly sensitive virology detection kit. Contents of the invention [0003] The purpose of the present invention is to overcome the defects of the prior art and provide a detection kit for novel coronavirus, which has strong specificity, high sensitivity, and the lowest detection limit reaches 10 -2 Copy / uL or less. [0004] The present invention is achieved like this: [0005] One of the objects of the present invention is to provide a crRNA for detecting novel coronavirus, said crRNA comp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/113C12Q1/6844C12Q1/70
CPCC12N15/113C12Q1/6844C12Q1/701G01N2333/165C12Q2521/507C12Q2522/101Y02A50/30
Inventor 裴兵耿晨
Owner 宿迁市第一人民医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products